Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Lancet 2021 Phase 2 (monotherapy) Lau et al., n=706, 26 weeks
One randomized placebo-controlled trial that assessed the effect of oral lipoic acid supplementation in 58 patients diagnosed with metabolic syndrome, a condition characterized by abnormal glucose and lipid metabolism, showed that flow-mediated vasodilation improved by 44% with 300 mg/day of lipoic acid for four weeks (66)
However, these side effects have not been proven to be caused by the treatment, so they do not manifest in all people
Keyaerts, M
Together they produce a larger, synergistic GH pulse than either alone
FOXO4-DRI is a unique synthetic peptide
US$ 20.42
US$ 26.39
US$ 25.31
